IP Library › Granted Patent US 10,065,949
Granted Patent B2
US 10,065,949 · App. 15/593,440 · Granted Sep 4, 2018

Method of preparing glucosylceramide synthase inhibitors

Inventors: Craig S. Siegel (Woburn, MA); Rayomand Gimi (Bridgewater, NJ); Michael Reardon (North Attleboro, MA); Jin Zhao (Framingham, MA)
Assignee: GENZYME CORPORATION
C07D453/02C07D277/30C07D417/06C07D417/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,065,949
App. No.
15/593,440
Granted
Sep 4, 2018
Kind
B2
Abstract

The invention relates to a method of preparing inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.

Claims (15)

1. A method of preparing the compound of Formula VIII

comprising reacting a compound of Formula IX

with quinuclidinol.

2. A method according to claim 1 , further including reacting the compound of Formula XI

with imidazole to form the compound of Formula IX

3. A method according to claim 1 , further including heating to reflux the compound of Formula XI

to form the compound of Formula X

4. A method according to claim 1 , further including reacting, while heating to reflux, the compound of Formula XI

with imidazole to form the compounds of Formula IX and Formula X

5. A method according to claim 2 , further including reacting the compound of Formula XII

with N, N′-carbonyldiimidazole to form the compound of Formula XI

6. A method according to claim 5 , further including reacting the compound of Formula XIII

with N, N′-carbonyldiimidazole and hydroxylamine to form the compound of Formula XII

7. A method according to claim 6 , further including reacting the compound of Formula XIV

with potassium tert-butoxide and methyl iodine followed by reacting the ethyl ester so formed with lithium hydroxide to form the compound of Formula XIII.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2018
From: SIEGEL, CRAIG; GIMI, RAYOMAND; REARDON, MICHAEL; ZHAO, JIN
To: GENZYME CORPORATION
Reel/Frame 045815/0471 →
Continuity (3)
Continuation 14776443
Provisional Application 61791913 · Mar 15, 2013
Related Publication 20170334903A1 · Nov 23, 2017
Cited By (2)
US 12,527,776 US 12,734,160